Breast cancer.
What’s therapeutic? Why is it therapeutic? Radiotherapy, short of medical treatment, based on the sensitivity of breast cancer cells to radiation, and the use of radiation to kill breast cancer cells, often as a supplementary means of treatment for breast cancer patients after surgery – – The most visible and concentrated of breast cancer cells are removed from surgery, but cancer cells may not be completely eliminated in local areas, including the transfer of some of them to nearby lymphocytes, so that the lethal effects of radioactivity on breast cancer cells are used to supplement missing cancer cells in order to prevent further growth, transformation, transfer and re-emergence of local breast cancer. Clinicians determine when the patient starts after the operation, depending on the actual condition of the patient.
What are the side effects of the treatment? There are mainly local skin changes, including deeper skin colours, hardened skin, red hair, ulcer, pain, and upper limb lymphoma, gastrointestinal reaction, lung radiation damage, heart toxicity, etc.
During the treatment, many patients are actively cooperating with the professional guidance of the medical therapist, and before the treatment, they learn from all possible channels about the “terror stories” of the second reaction to the treatment, so that they are worried about it during the treatment that they are troubled by both the doctor and themselves. A study on the release of secondary response included over 300 patients who had undergone breast cancer treatment, more than 50 per cent of whom said that they had heard “terror stories” about the release of secondary response before they received treatment, but only 2 per cent of patients eventually agreed with the horror stories, the vast majority of whom said that the actual post-release response was less serious than they thought.
This is due to the advances in modern treatment technology, more accurate exposures, less exposure time, and better restrictions on the emergence of therapeutic side-responses, and, of course, more importantly, the positive cooperation and understanding of patients.
References:
Zhang Huelan. Medical University, Beijing.
